China’s Li-NCT market is still in its early stages but holds massive growth potential due to significant investment in nuclear medicine and precision oncology. Government-backed initiatives under the “Healthy China 2030” plan are driving R&D in non-invasive, high-precision cancer therapies, making Li-NCT a promising candidate. A major driver is China’s rapidly growing cancer population, especially for tumors that are difficult to resect or treat with conventional methods. However, key restraints include the underdeveloped clinical trial ecosystem for neutron-based therapies and a lack of trained professionals in neutron oncology. A noticeable trend is the integration of AI with advanced imaging and neutron targeting systems, which may accelerate Li-NCT adoption in smart hospitals. Partnerships between state-owned enterprises and academic institutions, such as Tsinghua University and the China Institute of Atomic Energy, are facilitating prototype development and isotope production. Given China's centralized healthcare planning and potential for rapid infrastructure rollout, the Li-NCT market is poised to expand at an estimated CAGR of 17.5%, making it one of the most dynamic regions in the global neutron therapy landscape.
TABLE - China Lithium Neutron Capture Therapy Market Size & Forecast By Therapy Type 2021-2033
Therapy Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | CAGR (2024-2033) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Monotherapy | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Combination Therapy | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Total | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
Source: Company Publications, Primary Interviews, and SR Analysis
TABLE - China Lithium Neutron Capture Therapy Market Size & Forecast By Application 2021-2033
Application | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | CAGR (2024-2033) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brain Tumors | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Head and Neck Cancers | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Others | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Total | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
Source: Company Publications, Primary Interviews, and SR Analysis
TABLE - China Lithium Neutron Capture Therapy Market Size & Forecast By End-User 2021-2033
End-User | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | CAGR (2024-2033) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospitals with Advanced Radiotherapy Units | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Research Institutes | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Specialty Cancer Centers | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Total | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
Source: Company Publications, Primary Interviews, and SR Analysis